Works matching DE "IDARUBICIN"
Results: 169
Clinical and economic impact of drug eluting beads in transarterial chemoembolization for hepatocellular carcinoma.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2015, v. 40, n. 1, p. 83, doi. 10.1111/jcpt.12230
- By:
- Publication type:
- Article
Analysis of Candidate Idarubicin Drug Resistance Genes in MOLT-3 Cells Using Exome Nuclear DNA.
- Published in:
- Genes, 2018, v. 9, n. 8, p. 390, doi. 10.3390/genes9080390
- By:
- Publication type:
- Article
Delirium in acute promyelocytic leukemia patients: two case reports.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Chronic myelomonocytic leukaemia: leukaemia cutis predicts disease progression.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
A Phase II clinical trial of idarubicin administered to children with relapsed brain tumors.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Analysis to Estimate Genetic Variations in the Idarubicin-Resistant Derivative MOLT-3.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 1, p. 12, doi. 10.3390/ijms18010012
- By:
- Publication type:
- Article
Occurrence of myelodysplasia/acute myeloid leukemia 'on therapy' in two patients with acute promyelocytic leukemia.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells.
- Published in:
- Journal of Molecular Medicine, 2012, v. 90, n. 2, p. 149, doi. 10.1007/s00109-011-0814-7
- By:
- Publication type:
- Article
Apoferritin nanocages for targeted delivery of idarubicin against breast cancer cells.
- Published in:
- Biotechnology & Applied Biochemistry, 2022, v. 69, n. 3, p. 1061, doi. 10.1002/bab.2177
- By:
- Publication type:
- Article
A RARE CASE OF ACUTE MYELOID LEUKEMIA WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT.
- Published in:
- Acta Marisiensis. Seria Medica, 2024, v. 70, p. 216
- By:
- Publication type:
- Article
RESILIENCE: THE JOURNEY OF LEUKEMIA AND DIC IN A BREAST CARCINOMA SURVIVOR- CASE REPORT.
- Published in:
- Acta Marisiensis. Seria Medica, 2024, v. 70, p. 210
- By:
- Publication type:
- Article
New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 3, p. 700, doi. 10.3390/jcm14030700
- By:
- Publication type:
- Article
7 + 3 idarubicin is still an effective induction therapy in acute myeloid leukaemia.
- Published in:
- Internal Medicine Journal, 2014, v. 44, n. 8, p. 823, doi. 10.1111/imj.12492
- By:
- Publication type:
- Article
Author reply.
- Published in:
- Internal Medicine Journal, 2014, v. 44, n. 8, p. 825, doi. 10.1111/imj.12506
- By:
- Publication type:
- Article
High-dose cytarabine (24 g/m<sup>2</sup>) in combination with idarubicin ( HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia.
- Published in:
- Internal Medicine Journal, 2013, v. 43, n. 3, p. 294, doi. 10.1111/j.1445-5994.2012.02868.x
- By:
- Publication type:
- Article
Dismal outcome of therapy-related myeloid neoplasm associated with complex aberrant karyotypes and monosomal karyotype: a case report.
- Published in:
- Malaysian Journal of Pathology, 2016, v. 38, n. 3, p. 315
- By:
- Publication type:
- Article
Fludarabine, idarubicin, and cytarabine regimen together with TKI followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemia.
- Published in:
- Clinical Case Reports, 2016, v. 4, n. 4, p. 390, doi. 10.1002/ccr3.438
- By:
- Publication type:
- Article
MLL- ELL fusion gene in an acute myelomonocytic leukemia patient transformed from acute promyelocytic leukemia.
- Published in:
- Clinical Case Reports, 2015, v. 3, n. 6, p. 402, doi. 10.1002/ccr3.245
- By:
- Publication type:
- Article
Progressive hyperleukocytosis is a relevant predictive marker for differentiation syndrome, early death, and subsequent relapse in acute promyelocytic leukemia.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47937-4
- By:
- Publication type:
- Article
Acute myeloid leukemia 7 years after aleukemic leukemia cutis.
- Published in:
- International Journal of Dermatology, 2015, v. 54, n. 4, p. 459, doi. 10.1111/ijd.12024
- By:
- Publication type:
- Article
Alternate application of all-trans-retinoic acid and arsenic trioxide combined with idarubicin/daunorubicin in treatment of acute promyelocytic leukemia.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2022, v. 35, n. 1, p. 23, doi. 10.36721/PJPS.2022.35.1.REG.023-028.1
- By:
- Publication type:
- Article
Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 4, p. 557, doi. 10.1007/s00277-014-2242-6
- By:
- Publication type:
- Article
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)
- Published in:
- Annals of Hematology, 2014, v. 93, n. 6, p. 965, doi. 10.1007/s00277-014-2056-6
- By:
- Publication type:
- Article
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened 'GO question'.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1309, doi. 10.1007/s00277-013-1780-7
- By:
- Publication type:
- Article
Is obesity a prognostic factor for acute myeloid leukemia outcome?
- Published in:
- Annals of Hematology, 2012, v. 91, n. 3, p. 359, doi. 10.1007/s00277-011-1319-8
- By:
- Publication type:
- Article
Acute promyelocytic leukemia with additional chromosome abnormalities in a renal transplant case.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Coexistent cutaneous myeloid sarcoma in a patient with invasive papillary carcinoma of thyroid - A rare presentation.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
A prospective cohort study of methotrexate plus idarubicin in newly diagnosed primary CNS lymphoma.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 163, n. 1, p. 39, doi. 10.1007/s11060-022-04062-z
- By:
- Publication type:
- Article
Preparation, characterization and evaluation of <sup>186</sup>Re-idarubicin: a novel agent for diagnosis and treatment of hepatocellular carcinoma.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2016, v. 59, n. 2, p. 72, doi. 10.1002/jlcr.3368
- By:
- Publication type:
- Article
Postremission therapy with repeated courses of high‐dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long‐term outcome in European leukemia net favorable and intermediate‐risk acute myeloid leukemia
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 754, doi. 10.1002/hon.2806
- By:
- Publication type:
- Article
Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher‐risk myelodysplastic syndromes: a prospective multicenter single‐arm trial.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 531, doi. 10.1002/hon.2755
- By:
- Publication type:
- Article
Conventional and high-dose daunorubicin and idarubicin in acute myeloid leukaemia remission induction treatment: a mixed treatment comparison meta-analysis of 7258 patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
NPM1+ /FLT3- Acute Myeloid Leukemia after JAK2-V617F+ Essential Thrombocythemia. Management and Prognosis.
- Published in:
- Plasmatology, 2021, v. 15, p. 1, doi. 10.1177/26348535211028192
- By:
- Publication type:
- Article
Electrochemical Sensing of Idarubicin—DNA Interaction Using Electropolymerized Azure B and Methylene Blue Mediation.
- Published in:
- Chemosensors, 2022, v. 10, n. 1, p. 33, doi. 10.3390/chemosensors10010033
- By:
- Publication type:
- Article
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 11, p. 1301, doi. 10.1111/apt.12746
- By:
- Publication type:
- Article
A Sole p.G391E Mutation in PML::RARA Identified in Relapsed Acute Promyelocytic Leukemia.
- Published in:
- Turkish Journal of Hematology, 2024, v. 41, n. 3, p. 200, doi. 10.4274/tjh.galenos.2024.2024.0157
- By:
- Publication type:
- Article
Acute Basophilic Leukemia Arising from Chronic Myeloid Leukemia with Isolated Thrombocytosis.
- Published in:
- Turkish Journal of Hematology, 2021, v. 38, n. 4, p. 341, doi. 10.4274/tjh.galenos.2021.2021.0546
- By:
- Publication type:
- Article
Clinical Characteristics and Optimal Therapy of Acute Myeloid Leukemia with Myelodysplasia-Related Changes: A Retrospective Analysis of a Cohort of Chinese Patients.
- Published in:
- Turkish Journal of Hematology, 2021, v. 38, n. 3, p. 188, doi. 10.4274/tjh.galenos.2021.2021.0009
- By:
- Publication type:
- Article
PI3K Abrogation Using Pan-PI3K Inhibitor BKM120 Gives Rise to a Significant Anticancer Effect on AML-Derived KG-1 Cells by Inducing Apoptosis and G2/M Arrest.
- Published in:
- Turkish Journal of Hematology, 2020, v. 37, n. 3, p. 167, doi. 10.4274/tjh.galenos.2020.2019.0440
- By:
- Publication type:
- Article
Non-Leukemic Granulocytic Sarcoma Presenting with Multiple Lymphadenopathies.
- Published in:
- Turkish Journal of Hematology, 2017, v. 34, n. 2, p. 190, doi. 10.4274/tjh.2016.0428
- By:
- Publication type:
- Article
Wernicke’s Encephalopathy in an Acute Myeloid Leukemia Patient: A Case Study.
- Published in:
- Turkish Journal of Hematology, 2016, v. 33, p. 78, doi. 10.4274/tjh.2015.0249
- By:
- Publication type:
- Article
Acute leukemic appendicitis in a patient with acute promyelocytic leukemia.
- Published in:
- Journal of Cancer Research & Therapeutics, 2012, v. 8, n. 1, p. 132, doi. 10.4103/0973-1482.95194
- By:
- Publication type:
- Article
Palmoplantar exfoliation due to chloroquine.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Primary treatment of low-grade non-Hodgkin's lymphoma using an all oral anthracycline-containing regimen, chlorambucil, idarubicin, dexamethasone (CID)--a phase II study.
- Published in:
- 2000
- By:
- Publication type:
- journal article
In vitro evaluation of the reductive carbonyl idarubicin metabolism to evaluate inhibitors of the formation of cardiotoxic idarubicinol via carbonyl and aldo–keto reductases.
- Published in:
- Archives of Toxicology, 2024, v. 98, n. 3, p. 807, doi. 10.1007/s00204-023-03661-7
- By:
- Publication type:
- Article
A Case of Acute Myeloid Leukemia with a Previously Unreported Translocation (14; 15) (q32; q13).
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Life-Saving Effect of Corticosteroid and Colchicine Combination in Acute Myeloid Leukemia: Case Report.
- Published in:
- Middle East Journal of Cancer, 2022, v. 13, n. 3, p. 556, doi. 10.30476/mejc.2022.87974.1449
- By:
- Publication type:
- Article
Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3 -ITD in NPM1 Mutated AML, Irrespectively of FLT3 -ITD Allelic Burden.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 34, doi. 10.3390/cancers13010034
- By:
- Publication type:
- Article
Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3405, doi. 10.3390/cancers12113405
- By:
- Publication type:
- Article